| Regulated proteolysis of a cross-link–specific peptidoglycan hydrolase contributes to bacterial morphogenesis SK Singh, S Parveen, L SaiSree, M Reddy Proceedings of the National Academy of Sciences 112 (35), 10956-10961, 2015 | 131 | 2015 |
| Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma LS Cheung, J Fu, P Kumar, A Kumar, ME Urbanowski, EA Ihms, ... Proceedings of the National Academy of Sciences 116 (8), 3100-3105, 2019 | 63 | 2019 |
| Host-directed therapies: modulating inflammation to treat tuberculosis S Krug, S Parveen, WR Bishai Frontiers in immunology 12, 660916, 2021 | 49 | 2021 |
| Corynebacterium diphtheriae: Diphtheria Toxin, the tox Operon, and Its Regulation by Fe2+ Activation of apo-DtxR S Parveen, WR Bishai, JR Murphy Microbiology spectrum 7 (4), 10.1128/microbiolspec. gpp3-0063-2019, 2019 | 24 | 2019 |
| Identification of YfiH (PgeF) as a factor contributing to the maintenance of bacterial peptidoglycan composition S Parveen, M Reddy Molecular Microbiology 105 (5), 705-720, 2017 | 23 | 2017 |
| Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy P Kumar, A Kumar, S Parveen, JR Murphy, W Bishai Immunotherapy 11 (13), 1117-1128, 2019 | 18 | 2019 |
| Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model S Parveen, S Siddharth, LS Cheung, A Kumar, J Shen, JR Murphy, ... Molecular Onclology, 2021 | 17 | 2021 |
| IL-4 receptor targeting as an effective immunotherapy against triple-negative breast cancer S Parveen, S Siddharth, LS Cheung, A Kumar, JR Murphy, D Sharma, ... bioRxiv, 2020.08. 05.238824, 2020 | 6 | 2020 |
| Structural and mechanistic insights into EchAMP: A antimicrobial protein from the Echidna milk A Kumar, S Parveen, I Sharma, H Pathak, MV Deshmukh, JA Sharp, ... Biochimica et Biophysica Acta (BBA)-Biomembranes 1861 (6), 1260-1274, 2019 | 4 | 2019 |
| Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis S Parveen, J Shen, S Lun, L Zhao, J Alt, B Koleske, RD Leone, R Rais, ... Nature communications 14 (1), 7427, 2023 | 3 | 2023 |
| Effective host-directed therapy for tuberculosis by depletion of myeloid-derived suppressor cells and related cells using a diphtheria toxin fusion protein S Parveen, S Lun, ME Urbanowski, M Cardin, J Shen, JR Murphy, ... The Journal of Infectious Diseases 224 (11), 1962-1972, 2021 | 3 | 2021 |
| Targeting inhibitory cells such as Tregs and MDSCs in the tuberculous granuloma S Parveen, JR Murphy, WR Bishai Advances in Host-Directed Therapies Against Tuberculosis, 169-203, 2021 | 2 | 2021 |
| Imaging Tumor-Targeting Bacteria Using 18F-Fluorodeoxysorbitol Positron Emission Tomography SKJ Alvaro A Ordonez, Falk Saupe, Christoph A Kasper, Mitchell L Turner ... Journal of Infectious Diseases, 2023 | | 2023 |
| Transient and selective depletion of MDSCs and Tregs as an effective immunotherapy against triple-negative breast cancer S Parveen, S Siddharth, L Cheung, JR Murphy, D Sharma, WR Bishai Cancer Research 80 (16_Supplement), 6050-6050, 2020 | | 2020 |
| Abstract A54: Transient depletion of MDSCs and Tregs as an effective immunotherapy against triple-negative breast cancer (TNBC) S Parveen, S Siddharth, L Cheung, JR Murphy, D Sharma, WR Bishai Cancer Immunology Research 8 (3_Supplement), A54-A54, 2020 | | 2020 |
William BishaiProfessor of Medicine, Johns Hopkins UniversityVerified email at jhmi.edu
